Skip to main content
. 2019 Jan 24;9:716. doi: 10.1038/s41598-018-36902-2

Figure 5.

Figure 5

Role of p38 MAPK in the expression of LOC105375913 in tubular cells. (a) RT-PCR analysis of LOC105375913 in HK-2 cells treated with C3a, SB203580, PD098059 and MK2206 (n = 5); (b) RNA pull-down and RT-PCR analysis of the binding between LOC105375913 and miR-27b in HK-2 cells treated with C3a and SB203580 (n = 5); (c) Western blot analysis of snail, FN and Col I in HK-2 cells treated with C3a and SB203580 (n = 3); (d,e) Western blot analysis of p-p38 in HK-2 cells treated with C3a or plenti-CMV-LOC105375913 plasmid (n = 3); (f) RT-PCR analysis of LOC105375913 in HK-2 cells treated with U46619 (n = 5); (g) RNA pull-down and RT-PCR analysis of the binding between LOC105375913 and miR-27b in HK-2 cells treated with U46619 (n = 5); (h) Western blot analysis of snail, FN and Col I in HK-2 cells treated with U46619 (n = 3). For statistical analysis, one-way ANOVA with Tukey’s post hoc test was used for (a,b and g) and a two-tailed Student’s t-test was used for (f). *P < 0.05 compared with control. #P < 0.05 compared with C3a-treated cells.